Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Hair loss common in Norwegian men, affecting self-esteem and life quality.

Men can report their own balding patterns well enough for large health studies.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

High TNF-α levels may increase hair loss risk after PRP therapy.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Baldness may lower the risk of testicular cancer.